University scientists are trained to focus intensively on their field of research. But if their ideas have business potential then a world outside the university walls appears – and different skills are needed.
Habib Frost is everything that Danish Universities and Denmark in general is craving for: A young, bright medical doctor, who has initiated a promising business adventure. In 2015 he won Denmark’s best idea (Danske Ideer) at Singularity University in Denmark, and attended their 10-week Flagship Program at NASA Ames in Silicon Valley.
Now his medtech company, Neurescue is working on a device with the potential to save millions of lives all over the world.
“Most of the researchers who have reached as far as developing an idea ready for spin-out have the ability to stay focused and work hard on their own, and this intense intellectual pursuit is paramount,” says Habib Frost.
The right mix of proficiencies In Denmark the level of education is high, and there is a well-established tradition of cross-disciplinary collaboration between the universities. But other skills are also needed.
“We need to remix and match with others – with people from many different backgrounds such as experts in finance and business,” says Habib Frost. ”People have generously shared their networks and given me advice and referrals. This type of environment fosters support and collaboration. In Copenhagen Science City all you have to do is walk a hundred meters, and you’ll find somebody who knows what you need, or can tell you where to go.”
And Habib Frost knows what he’s talking about, because he did the walk a number of times. As a result Neurescue is off to a good start and is in rapid development.
“Unless we get out of our ivory towers we risk missing out on wonderful initiatives and applications.”
Habib Frost, Neurescue
Bringing blood to organs in need Neurescue builds on the idea that lives can be saved in medical emergencies, such as cardiac arrest, by redistribution of blood to the most vulnerable organs in the body: heart and brain.
The company is developing a device, the Neurescue™, which is a small computer-controlled balloon catheter to be placed in the aorta through a small needle puncture in the leg. The balloon occludes the aorta and thereby redirects the blood.
The procedure increases the likelihood of resuscitation and reduces the risk of brain damage.
The Neurescue™ device has been tested in several pig studies, and they are currently in the process of an investment round to develop the clinical version of the product.